NO20053788L - Anvendelse av lupin-konglutin for behandlingen av type II diabetes. - Google Patents
Anvendelse av lupin-konglutin for behandlingen av type II diabetes.Info
- Publication number
- NO20053788L NO20053788L NO20053788A NO20053788A NO20053788L NO 20053788 L NO20053788 L NO 20053788L NO 20053788 A NO20053788 A NO 20053788A NO 20053788 A NO20053788 A NO 20053788A NO 20053788 L NO20053788 L NO 20053788L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes
- treatment
- type
- conglutin gamma
- lupin conglutin
- Prior art date
Links
- 241000219745 Lupinus Species 0.000 title abstract 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 abstract 5
- 101710155000 Gamma conglutin 1 Proteins 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
2005-11-11 S a m m e n d r a g Foreliggende oppfinnelse beskriver anvendelse av lupinkonglutin gamma eller av proteiner med homologi høyere enn 50% med lupin-konglutin gamma, for fremstilling av et medikament, mattilsetninger eller mat for behandlingen av type II diabetes, farmasøytiske eller ernæringssammensetninger inneholdende lupin-konglutin gamma og anvendelse av lupin-konglutin gamma som terapeutisk middel, spesielt som hypoglykemiserende middel. Lupinkonglutin gamma kan anvendes i ren form eller i form av ekstrakter, blandinger eller konsentrater.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000237A ITMI20030237A1 (it) | 2003-02-11 | 2003-02-11 | Uso della conglutina di lupino per il trattamento del |
| PCT/EP2004/001111 WO2004071521A1 (en) | 2003-02-11 | 2004-02-06 | The use of lupin conglutin for the treatment of type ii diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20053788D0 NO20053788D0 (no) | 2005-08-10 |
| NO20053788L true NO20053788L (no) | 2005-11-11 |
| NO333224B1 NO333224B1 (no) | 2013-04-15 |
Family
ID=32866063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053788A NO333224B1 (no) | 2003-02-11 | 2005-08-10 | Anvendelse av lupin-konglutin gamma for behandling av type II diabetes og farmasoytiske eller ernaeringssammensetninger inneholdene lupin-konglutin gamma. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7323441B2 (no) |
| EP (1) | EP1605957B1 (no) |
| JP (2) | JP2006517212A (no) |
| KR (2) | KR101084434B1 (no) |
| CN (1) | CN1747739B (no) |
| AT (1) | ATE391510T1 (no) |
| AU (1) | AU2004212297B2 (no) |
| CA (1) | CA2515607C (no) |
| CY (1) | CY1108138T1 (no) |
| DE (1) | DE602004012984T2 (no) |
| DK (1) | DK1605957T3 (no) |
| ES (1) | ES2303937T3 (no) |
| IL (1) | IL170200A (no) |
| IT (1) | ITMI20030237A1 (no) |
| NO (1) | NO333224B1 (no) |
| PL (1) | PL214193B1 (no) |
| PT (1) | PT1605957E (no) |
| RU (1) | RU2339393C2 (no) |
| SI (1) | SI1605957T1 (no) |
| WO (1) | WO2004071521A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
| US8609161B2 (en) | 2008-05-30 | 2013-12-17 | Ospedale San Raffaele S.R.L. | Conglutin-gamma as medicament and diet supplement |
| EP2411137B1 (en) | 2009-03-27 | 2016-09-07 | Bend Research, Inc. | Spray-drying process |
| EP2611530B1 (en) | 2010-09-03 | 2019-01-16 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| US9084976B2 (en) | 2010-09-03 | 2015-07-21 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| EP2618924A1 (en) | 2010-09-24 | 2013-07-31 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
| CA2814428C (en) * | 2010-10-12 | 2018-04-10 | Consumo Em Verde - Biotecnologia Das Plantas, S.A. | Antimicrobial protein |
| CA2953644C (en) | 2014-06-30 | 2020-08-11 | Prolupin Gmbh | Emulsion with lupine protein |
| US11364203B2 (en) | 2014-10-31 | 2022-06-21 | Bend Reserch, Inc. | Process for forming active domains dispersed in a matrix |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
| JPH08127538A (ja) * | 1994-10-31 | 1996-05-21 | Masakiyo Takahashi | 糖尿病治療薬 |
| JPH0967252A (ja) * | 1995-09-05 | 1997-03-11 | Zenkoku Royal Jelly Kosei Torihiki Kiyougikai | ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤 |
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
-
2003
- 2003-02-11 IT IT000237A patent/ITMI20030237A1/it unknown
-
2004
- 2004-02-06 DK DK04708771T patent/DK1605957T3/da active
- 2004-02-06 PT PT04708771T patent/PT1605957E/pt unknown
- 2004-02-06 PL PL377578A patent/PL214193B1/pl unknown
- 2004-02-06 SI SI200430714T patent/SI1605957T1/sl unknown
- 2004-02-06 AU AU2004212297A patent/AU2004212297B2/en not_active Ceased
- 2004-02-06 RU RU2005125411/15A patent/RU2339393C2/ru not_active IP Right Cessation
- 2004-02-06 ES ES04708771T patent/ES2303937T3/es not_active Expired - Lifetime
- 2004-02-06 CN CN2004800039114A patent/CN1747739B/zh not_active Expired - Fee Related
- 2004-02-06 US US10/545,103 patent/US7323441B2/en not_active Expired - Lifetime
- 2004-02-06 AT AT04708771T patent/ATE391510T1/de active
- 2004-02-06 DE DE602004012984T patent/DE602004012984T2/de not_active Expired - Lifetime
- 2004-02-06 CA CA2515607A patent/CA2515607C/en not_active Expired - Fee Related
- 2004-02-06 JP JP2006501760A patent/JP2006517212A/ja not_active Withdrawn
- 2004-02-06 KR KR1020057014390A patent/KR101084434B1/ko not_active Expired - Fee Related
- 2004-02-06 KR KR1020117005984A patent/KR20110033312A/ko not_active Withdrawn
- 2004-02-06 EP EP04708771A patent/EP1605957B1/en not_active Expired - Lifetime
- 2004-02-06 WO PCT/EP2004/001111 patent/WO2004071521A1/en not_active Ceased
-
2005
- 2005-08-10 NO NO20053788A patent/NO333224B1/no not_active IP Right Cessation
- 2005-08-10 IL IL170200A patent/IL170200A/en active IP Right Grant
-
2008
- 2008-06-12 CY CY20081100628T patent/CY1108138T1/el unknown
-
2012
- 2012-04-26 JP JP2012100564A patent/JP5504301B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| WO2001028356A3 (en) | Food supplement for increasing lean mass and strength | |
| HK1049431A1 (zh) | 用於增加肌肉塊和力量的食物補充方法 | |
| MXPA05009933A (es) | Composiciones que comprenden acidos grasos y aminoacidos. | |
| PL1898724T3 (pl) | Preparat odżywczy dla niemowląt z hydrolizowanymi białkami | |
| NO20050896L (no) | Probiotika for neuromuskulaere funksjoner i tarmen | |
| BR0308799A (pt) | co-glóbulos de dha e alecrim e método de uso | |
| GEP20063818B (en) | Orodispersible pharmaceutical composition comprising agomelatine | |
| WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
| DE60012301D1 (de) | Lipoproteinkomplexe und zusammensetzungen, die diese enthalten | |
| WO2008087365A3 (fr) | Derives de 1,3-diphenylpropane substitues, preparations et utilisations | |
| BR0308713A (pt) | Co-esférula de dha e alecrim, e métodos de uso | |
| AU2003207417A1 (en) | Use of tryptophan rich peptides | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| IL172916A0 (en) | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance | |
| WO2012049430A3 (fr) | Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices | |
| GEP20063821B (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| BRPI0410761A (pt) | uso de leucina, e, composição para administração entérica a pacientes | |
| JP2017057147A (ja) | ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物 | |
| AR045745A1 (es) | Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2 | |
| WO2002089741A3 (en) | Compositions and methods for enhancing drug delivery | |
| PT1581239E (pt) | Utilização precoce de um extracto de folhas de videira vermelha | |
| MY184130A (en) | Peptidic growth hormone secretagogues analog compounds and preparations thereof | |
| DK1497250T3 (da) | Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse | |
| ATE405584T1 (de) | Arginin/lysin-angereicherte peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |